WASHINGTON — The trade group for the pharmaceutical industry on Friday sued to block a new process, outlined by the Trump administration, that aimed to help drug makers and health care providers resolve disputes over a federal drug discount program.
The suit is the latest in a flurry of recent legal actions between the Department of Health and Human Services, providers, and the pharmaceutical industry, after several drug makers aggressively cut back on the pharmacies they would allow to dispense discounted drugs through the 340B program last summer.
About the Author Reprints
If I could have read the whole story yes I would absolutely subscribe for my company.and how are you gonna advertise part of a very important story.I am angry because Google put ur ad on an. it was infuryating and very disappointing on only reading half a story and pay 365.00 wow during this pandemic that’s real sorry…so sorryyou lost my account.Good day